Enbridge Is Still Under $61. Here's Whether Long-Term Investors Should Pounce.

Enbridge's adjusted EBITDA grew at a 9.3% CAGR to C$19.95bn (2025) and DCF per share rose 3.6% CAGR to C$5.71; guidance for 2026 is EBITDA C$20.2–20.8bn and DCF/sh C$5.70–6.10, which comfortably covers the C$3.88 dividend (≈5.2% yield). Shares trade around C$75 (~12% below a C$85 analyst top target), implying roughly 13x this year's midpoint DCF and ~14x adjusted EBITDA; the company completed a C$14bn utility acquisition, has C$8bn of projects coming online, and is expanding renewables, supporting its defensive, income-oriented thesis.

Analysis

Enbridge’s repositioning toward regulated US utilities and European renewables meaningfully changes the return profile from pure toll-road midstream to a mixed bucket of regulated rate-base growth and project development. That bifurcation reduces commodity sensitivity but raises exposure to multi-year rate cases, project delivery risk and different capital markets (utility-style project finance vs midstream debt). Contractors and equipment suppliers along the electrification/renewables chain (transformer makers, grid-control software vendors, HVDC contractors) become second-order beneficiaries of ongoing capital intensity, creating potential sourcing bottlenecks and margin pressure on timelines if multiple large projects coincide.

Interest-rate and FX dynamics are the non-obvious lever for Enbridge’s equity rerating: regulated cash flows can be long-duration and vulnerable to higher-for-longer rates when projects are financed at floating spreads, while cross-border cash conversions and hedging demand will shape retained free cash. A mid-term catalyst set to move the stock is clarity on financing strategy for the utility assets (equity raises vs asset sales vs term debt), not commodity prices; a surprise equity issuance or downward revision to project timing would be the fastest negative shock.

Consensus treats the business as recession-proof; the contrarian risk is that decarbonization accelerates asset stranding risk for hydrocarbon pipelines over a 5-10 year window and forces tougher regulatory scrutiny on terminal/long-haul projects. That creates an asymmetric opportunity: own the yield while buying optionality into regulated growth, but explicitly size and hedge for regulatory and financing tail events rather than relying on dividend stability alone.

Key Decisions for Investors

• Core income trade (12–24 months): Buy ENB equity sized to be no more than 2–3% of portfolio for steady cash yield; overlay a 9–12 month 15% OTM put for downside protection (cost ~1–3% of notional). R/R: target 10–18% total return if no large regulatory shock; protected drawdown limited to put cost plus strike gap.
• Yield-enhancement (6–9 months): Buy ENB shares and sell 6-month covered calls at ~10% OTM to boost cash yield by ~3–5% annualized. R/R: expect modest upside plus enhanced yield; cap upside beyond call strike, retain downside exposure.
• Tail hedge + asymmetric upside (18–36 months): Buy ENB 24–36 month LEAP calls 30–40% OTM (~limited premium) financed by selling nearer-term calls to pay part of premium. R/R: small premium buys optionality on rerating if financing risk is resolved; max loss = premium paid.
• Tactical pair (3–12 months): Relative-defensive pair — go long ENB (smaller size) and short NVDA (smaller size) to express resilience of regulated cash vs AI cyclicality; size to net neutral beta. R/R: if tech derates, expect ENB to outperform; downside if AI capex continues surprising to the upside.
• Watchlist trigger: Reduce ENB gross exposure immediately upon evidence of an equity raise or a major adverse regulatory ruling (state or federal) — predefine cut to 50% of position within 5 trading days of announcement to protect against rapid de-rating.